A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

Illumina, Inc. ILMN has secured the FDA’s approval for its in vitro diagnostic (IVD) TruSight Oncology (TSO) Comprehensive test and first two companion diagnostic (CDx) indications. The test analyses ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Michigan-based Priority Health plans a bold step in cancer detection and treatment: It will cover the cost of comprehensive genomic profiling for members diagnosed with aggressive forms of cancer, ...

NEW YORK, June 25, 2025--(BUSINESS WIRE)--Levels, the health technology company known for pioneering real-time glucose insights for health-conscious consumers, today introduced its most robust ...